Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.37%
SPX
-0.06%
IXIC
-0.05%
FTSE
+0.37%
N225
+1.85%
AXJO
+0.43%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Regenxbio News

prnewswire.com

REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare from prnewswire.com
4 days ago
benzinga.com

A Glimpse Into The Expert Outlook On Regenxbio Through 8 Analysts

2 months ago
benzinga.com

Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer

Feature Image for interests on Biotech, Briefs, Health Care, Healthcare from benzinga.com
2 months ago
benzinga.com

Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday

Feature Image for interests on Basic Materials, Big Gainers, Healthcare, Mid Day Movers from benzinga.com
2 months ago
finance.yahoo.com

REGENXBIO Presents Positive Data from the Phase II Study of Subretinal ABBV-RGX-314 in Patients with Bilateral Wet AMD at AAO 2024

Feature Image for interests on -- Regenxbio Inc., Arshad Khanani, Durable Treatment Effect, Gene Therapy from finance.yahoo.com
10 months ago
finance.yahoo.com

Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

Feature Image for interests on Cancer Patients, Chief Executive Officer, Chief Scientific Officer, Development from finance.yahoo.com
10 months ago
finance.yahoo.com

REGENXBIO Appoints Mitchell Chan as Chief Financial Officer

Feature Image for interests on Chan, Executive Vice President, Gene Therapy, Healthcare from finance.yahoo.com
11 months ago
finance.yahoo.com

RegenxBio touts positive data for rare disease drug RGX-121

Feature Image for interests on Cerebrospinal Fluid, Dose Escalation Study, Dose Level, Gene Therapy from finance.yahoo.com
11 months ago
finance.yahoo.com

RegenxBio touts positive data for rare disease drug RGX-121

Feature Image for interests on Cerebrospinal Fluid, Dose Escalation Study, Dose Level, Gene Therapy from finance.yahoo.com
11 months ago
finance.yahoo.com

REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect

Feature Image for interests on Gene Therapy, Healthcare, Mps Ii, Mucopolysaccharidosis Type from finance.yahoo.com
11 months ago

Latest Cashu News

publisher logo
Cashu

REGENXBIO Launches Pivotal Trial for Gene Therapy in Diabetic Retinopathy

3 days ago
publisher logo
Cashu

Regenxbio: Navigating Mixed Analyst Sentiment in Gene Therapy Innovations

2 months ago
publisher logo
Cashu

RegenXBio's RGX-202 Shows Promise in Duchenne Muscular Dystrophy Gene Therapy Trial

2 months ago
Stocks
Health Care
rgnx
Regenxbio
NASDAQ: RGNX
-0.44 (-5.67%)
7.405
USD
At close at Aug 11, 17:40 UTC
Summary
News
Signals
Benchmarks
Financials